Effectiveness of treatment for prostate cancer in Villa Clara

Authors

  • Freddy Castillo Guerra Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba
  • Lissi Lisbet Rodríguez Rodríguez Hospital Asistencial “Celestino Hernández Robau”, Santa Clara, Villa Clara, Cuba
  • Olga Lidia Alfonso Pérez
  • Julio César Vigil Quiñonez Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba
  • Raúl Santiago López Monte Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba
  • José Luis Teyes Serrano Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba

Keywords:

prostatic neoplasms, treatment outcome

Abstract

A retrospective analytical study was conducted to determine the differences in prostate cancer treatment with radiotherapy and radiotherapy plus hormone therapy in the province of Villa Clara from January 2000 to December 2006. The universe consisted of 70 patients diagnosed with prostate cancer who were treated at the Radiotherapy Service of the Celestino Hernandez Robau Provincial Hospital in this period. After the implementation of the authorial criteria, the data were obtained from the medical records. The patients were studied and it was determined what type of treatment would be used according to the proposed modalities: a monotherapy with radiotherapy, radiation therapy combined with hormone therapy and radiation therapy combined with androgenic block. The complications of such treatments were determined: the most common are the immediate ones, secondary to radiation therapy, mainly radiation dermatitis, cystitis, and urinary frequency. Five-year survival was better when both treatments were combined, and biochemical progression was less in that therapeutic modality. It is recommend an orchiectomy, and radiation therapy associated with oral estrogen.

Downloads

Download data is not yet available.

Author Biographies

Freddy Castillo Guerra, Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba

Especialista de I Grado en Urología. Máster en Longevidad Satisfactoria. Profesor Instructor de la Universidad de Ciencias Médicas de Villa Clara “Dr. Serafín Ruiz de Zárate Ruiz”.

Lissi Lisbet Rodríguez Rodríguez, Hospital Asistencial “Celestino Hernández Robau”, Santa Clara, Villa Clara, Cuba

Especialista de I Grado en Oncología. Máster en Longevidad Satisfactoria. Profesora Instructora de la Universidad de Ciencias Médicas de Villa Clara “Dr. Serafín Ruiz de Zárate Ruiz”.

Olga Lidia Alfonso Pérez

Licenciada en Enfermería. Máster en Atención Integral al Niño. Profesora Asistente de la Universidad de Ciencias Médicas de Villa Clara “Dr. Serafín Ruiz de Zárate Ruiz”.

Julio César Vigil Quiñonez, Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba

Especialista de I Grado en Urología. Profesor Asistente de la Universidad de Ciencias Médicas de Villa Clara “Dr. Serafín Ruiz de Zárate Ruiz”.

Raúl Santiago López Monte, Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba

Especialista de I Grado en Urología. Profesor Asistente de la Universidad de Ciencias Médicas de Villa Clara “Dr. Serafín Ruiz de Zárate Ruiz”.

José Luis Teyes Serrano, Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba

Especialista de I Grado en Medicina General Integral. Residente de Urología.

Downloads

How to Cite

1.
Castillo Guerra F, Rodríguez Rodríguez LL, Alfonso Pérez OL, Vigil Quiñonez JC, López Monte RS, Teyes Serrano JL. Effectiveness of treatment for prostate cancer in Villa Clara. Acta Méd Centro [Internet]. 2011 Jul. 1 [cited 2025 Jul. 1];5(3):3-12. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/648

Issue

Vol. 5 No. 3 (2011): July-Septembre. Special Issue of Hospital Scientifics Event

Section

Oncology

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).